Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 14Polycystic Ovary Syndrome 13Leiomyoma 8Menorrhagia 7Prostatic Neoplasms 2Osteoporosis 2Neoplasm Metastasis 2Hyperandrogenism 2Vaginitis 1Triple Negative Breast Neoplasms 1Sexual Dysfunction, Physiological 1Pregnancy Complications 1Postmenopausal Vaginal Atrophy 1Neoplasms 1Infertility, Female 1Infertility 1Hot Flashes 1Estrogen Receptor Positive Breast Cancer 1Estrogen Levels Among Breast Cancer Patients 1Endometriosis 1Coronary Disease 1Cardiovascular Diseases 1Breast Carcinoma In Situ 1Atrophic Vaginitis 1Anemia 1Anatomic Stage III Breast Cancer AJCC v8 1Abortion, Spontaneous 1

Interventions

Estradiol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Postmenopausal Vaginal Atrophy × Estradiol × Clear all
NCT05243823 2022-12-23

Vaginal Estradiol Tablets (Vagifem®) and Endometrial Cancer Risk in the Treatment of Postmenopausal Vaginal Atrophy

Novo Nordisk A/S

Completed
500,000 enrolled

Postmenopausal Vaginal Atrophy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡